Grants and Contributions

This prize was established to honour the past Scientific Director of the CIHR Institute of Aging, Yves Joanette, for his outstanding contributions to the area of research on aging in Canada and Internationally.

This prize will be given annually to the highest-ranking funded project in the Project Grant competition that is relevant to one of the Institute of Aging’s areas as outlined in the CIHR IA Strategic Plan 2023-2028: Reframing Aging Empowering Older Adults.

This prize is a supplemental grant to support research and has to be used according to the CIHR Grants and Awards Guide. The prize is not a personal award and is non-renewable.

This prize was established to honour the past Scientific Director of the CIHR Institute of Aging, Yves Joanette, for his outstanding contributions to the area of research on aging in Canada and Internationally.

This prize will be given annually to the highest-ranking funded project in the Project Grant competition that is relevant to one of the Institute of Aging’s areas as outlined in the CIHR IA Strategic Plan 2023-2028: Reframing Aging Empowering Older Adults.

This prize is a supplemental grant to support research and has to be used according to the CIHR Grants and Awards Guide. The prize is not a personal award and is non-renewable.

This prize was established to recognize the excellence of research in aging being conducted in Canada. This prize will be given annually to the top investigators with the highest ranking project in the Fall Project Grant competition that is relevant to one of the Institute of Aging’s areas as outlined in the CIHR IA Strategic Plan 2023-2028: Reframing Aging Empowering Older Adults.

This prize is a supplemental grant to support research and must be used according to the CIHR Grants and Awards Guide. The prize is not a personal award and is non-renewable.

The CIHR Institute of Cancer Research (CIHR-ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.

This PA will fund Breast Cancer research in the following priority areas:

• General Breast Cancer Research
o research that supports CIHR-ICR’s mandate in the area of Breast Cancer
• Breast Cancer Prevention and/or Early Detection of Breast Cancer
o research that prevents the onset of breast cancer (lowers cancer risk) and/or reduces the severity of the disease through early detection when it is at its most treatable.
• Breast Cancer Survivorship
o research that mitigates the challenges experienced along the breast cancer survivorship journey and improves the health outcomes for breast cancer survivors of all ages from the time of their cancer diagnosis until the time of their death or entry into end-of-life care.
o specifically in the areas of:
¿ Late & Long-Term Effects
¿ Survivors’ Experiences & Outcomes
¿ Models of Care
o This PA will not fund research focused on improving end-of-life care.

• This PA supports research that creates new knowledge and/or moves it into practice in the health system, communities, workplaces, and in the daily lives of Canadians.

The CIHR Institute of Cancer Research (CIHR-ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.

This PA will fund Breast Cancer research in the following priority areas:

• General Breast Cancer Research
o research that supports CIHR-ICR’s mandate in the area of Breast Cancer
• Breast Cancer Prevention and/or Early Detection of Breast Cancer
o research that prevents the onset of breast cancer (lowers cancer risk) and/or reduces the severity of the disease through early detection when it is at its most treatable.
• Breast Cancer Survivorship
o research that mitigates the challenges experienced along the breast cancer survivorship journey and improves the health outcomes for breast cancer survivors of all ages from the time of their cancer diagnosis until the time of their death or entry into end-of-life care.
o specifically in the areas of:
¿ Late & Long-Term Effects
¿ Survivors’ Experiences & Outcomes
¿ Models of Care
o This PA will not fund research focused on improving end-of-life care.

• This PA supports research that creates new knowledge and/or moves it into practice in the health system, communities, workplaces, and in the daily lives of Canadians.

The specific objective of this funding opportunity is to:

• Catalyze and support research efforts of Canadian researchers to use the available CLSA data in order to better understand how biological, medical, psychological, social, lifestyle and/or economic aspects of people’s lives have an impact on both maintaining health and the development of disease and disability as people age.

The CIHR Institute of Circulatory and Respiratory Health (CIHR-ICRH) has the broad mandate of supporting research on the heart, lung, brain (stroke), blood, blood vessels, critical and intensive care, and sleep.
This Priority Announcement is focused on conditions of the heart and of the circulatory system across the lifespan, including but not limited to data acquisition.
• The proposed research should inform the management of early risk factors for cardiac and non-cardiac complications of cardiovascular conditions.
• Research focusing on more than one (1) developmental or intergenerational period over the lifespan is encouraged. Examples include, but are not limited to:
o one developmental period before and after age 18, or
o different developmental periods across generations (e.g. biological parent and fetus or offspring), or
o two (2) developmental periods in females related to puberty, child-bearing age and menopause.
• Sex and gender consideration should be integrated as appropriate.

This award was established to recognize the excellence of cancer research being conducted in Canada. This award will be given annually to the highest-ranking Early Career Researchers in the Project Grant competition that fall within the CIHR Institute of Cancer Research (CIHR-ICR) mandate:

• ICR has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.

CIHR is committed to leverage the power of research to accelerate global health equity for all. The CIHR Framework for Action on Global Health Research 2021-2026 recognizes that CIHR must work globally because today’s most pressing health problems, and many of the most effective strategies to prevent, contain, and address them, are global. In alignment with this Framework, this priority announcement aims to grow global health research capacity and excellence.
Funding will be provided for applications that have a primary focus on global health research (as per CIHR’s definition) and that are relevant to one of the mandates below:
• Centre for Research on Pandemic Preparedness and Health Emergencies (CRPPHE)
• Institute of Population and Public Health (IPPH)

The specific objectives of this funding opportunity are:
• To provide recognition and funding to academic health research trainees;
• To provide a reliable supply of highly skilled and qualified researchers.